1 | what | 6,740 |
2 | 'what | 49 |
3 | nowhere | 15 |
4 | 'have | 9 |
5 | swach | 8 |
6 | 'would | 6 |
7 | pde1c | 6 |
8 | br38 | 5 |
9 | bucast | 5 |
10 | ingn-225 | 5 |
11 | mk-0888 | 5 |
12 | donna | 4 |
13 | dos3 | 4 |
14 | s1333 | 4 |
15 | zmhsp17.8-cii | 4 |
16 | c48b6n6 | 3 |
17 | caenophanes | 3 |
18 | cardiac-ct | 3 |
19 | cyathostomins | 3 |
20 | deoxyspergualin | 3 |
21 | giig | 3 |
22 | hypochromy | 3 |
23 | leisure-related | 3 |
24 | liliopsida | 3 |
25 | neville | 3 |
26 | protocol-related | 3 |
27 | re-start | 3 |
28 | retro-cuing | 3 |
29 | rhaiii | 3 |
30 | whoever | 3 |
31 | α-li3bn2 | 3 |
32 | 'which | 2 |
33 | -junction | 2 |
34 | /test | 2 |
35 | 25.224 | 2 |
36 | atg14-vps30 | 2 |
37 | bless | 2 |
38 | brd7/9 | 2 |
39 | carmel | 2 |
40 | cedecea | 2 |
41 | cenes | 2 |
42 | cml-peptide | 2 |
43 | ddms | 2 |
44 | dynquest | 2 |
45 | htlvs | 2 |
46 | illness-spectrum | 2 |
47 | immunodrugs | 2 |
48 | kristin | 2 |
49 | kushta | 2 |
50 | man7glcnac2 | 2 |
51 | namisol | 2 |
52 | octrestatin | 2 |
53 | p50/rela | 2 |
54 | peniscopy | 2 |
55 | progesteron | 2 |
56 | rewording | 2 |
57 | rochon | 2 |
58 | rs/ef | 2 |
59 | sulfamides | 2 |
60 | svm-ref | 2 |
61 | syngnathids | 2 |
62 | “what | 2 |
63 | ''what | 1 |
64 | 'giving | 1 |
65 | -1,4,5,6,7,8-hexahydroquinoline-3-carboxamide | 1 |
66 | -2-methylbutanoyl-l-serine | 1 |
67 | -27b | 1 |
68 | -30a-5p | 1 |
69 | -5ralpha | 1 |
70 | -avf | 1 |
71 | -coordinator | 1 |
72 | -cyclometalation | 1 |
73 | -depressants | 1 |
74 | -diffusion | 1 |
75 | -endogas | 1 |
76 | -isoamyl-3-hydroxybutanoate | 1 |
77 | -italy | 1 |
78 | -learning | 1 |
79 | -opo2o | 1 |
80 | -pacing | 1 |
81 | -tace | 1 |
82 | -β/δ | 1 |
83 | .breezhaler | 1 |
84 | .dha-p | 1 |
85 | .morphine | 1 |
86 | .selenium | 1 |
87 | .tavr | 1 |
88 | .trabectedin | 1 |
89 | //health.bsd.uchicago.edu/yji/soft.html | 1 |
90 | /c-dots | 1 |
91 | /ccn6 | 1 |
92 | /crt | 1 |
93 | /dhcr24 | 1 |
94 | /dkk-3 | 1 |
95 | /mi | 1 |
96 | /mxr/abcg2 | 1 |
97 | /tescalcin | 1 |
98 | 04/30/95 | 1 |
99 | 0804 | 1 |
100 | 1,3-dihydroindol-2-ones | 1 |
101 | 1-what | 1 |
102 | 103f | 1 |
103 | 11q22-q23 | 1 |
104 | 130427a | 1 |
105 | 130k | 1 |
106 | 16_a2d | 1 |
107 | 1a1*28 | 1 |
108 | 1mg/kg/d | 1 |
109 | 2-what | 1 |
110 | 2011.results | 1 |
111 | 2014cancer | 1 |
112 | 213,543 | 1 |
113 | 23author | 1 |
114 | 3'-isomerization | 1 |
115 | 40-120mg/day | 1 |
116 | 45kd | 1 |
117 | 489nm | 1 |
118 | 5,353 | 1 |
119 | 580nm | 1 |
120 | 9254 | 1 |
121 | adherence/exposure | 1 |
122 | alpha-glucosaminide | 1 |
123 | antigp2b3a | 1 |
124 | anxiety.there | 1 |
125 | aot/ccot | 1 |
126 | baishaoyao | 1 |
127 | bambusaceae | 1 |
128 | bbb-penetration | 1 |
129 | benzoyl-groups | 1 |
130 | benzoylhypacoitine | 1 |
131 | bio-membranes | 1 |
132 | biomodeling | 1 |
133 | blockbusters | 1 |
134 | c-trial | 1 |
135 | c.marina | 1 |
136 | c/ebp-beta | 1 |
137 | caldes | 1 |
138 | carbanions | 1 |
139 | carbitocin | 1 |
140 | cbm32 | 1 |
141 | cca1-e189f | 1 |
142 | cd25/cd95 | 1 |
143 | cephaladic | 1 |
144 | chulay | 1 |
145 | clinicaltrials.govnct00162682 | 1 |
146 | clinicaltrials.govnct01202383 | 1 |
147 | co-transport | 1 |
148 | cognitive-motivational | 1 |
149 | consideres | 1 |
150 | correct-the | 1 |
151 | crd42011001209 | 1 |
152 | crisis/emergent | 1 |
153 | ctip/ctbp | 1 |
154 | cullins | 1 |
155 | cys289 | 1 |
156 | cytosolic-wasp | 1 |
157 | des-venlafaxine | 1 |
158 | desmopressin.there | 1 |
159 | dihydro-1,3-benzoxazines | 1 |
160 | downfondaparinux | 1 |
161 | drug.there | 1 |
162 | efavirens | 1 |
163 | epithelia/endothelia | 1 |
164 | epy | 1 |
165 | eradicate.this | 1 |
166 | etconhc6h5 | 1 |
167 | euforbiaceae | 1 |
168 | exchange-relevant | 1 |
169 | experimental-treatment | 1 |
170 | f420h2 | 1 |
171 | fe-f6 | 1 |
172 | few-layered | 1 |
173 | food-reward | 1 |
174 | frenzel | 1 |
175 | frhb | 1 |
176 | glyco-proteomics | 1 |
177 | hausera | 1 |
178 | havcr1/kim-1 | 1 |
179 | hbot.there | 1 |
180 | high-fat/lower | 1 |
181 | his359 | 1 |
182 | hla-drβ1*04:02 | 1 |
183 | homoproline | 1 |
184 | hospital.this | 1 |
185 | hsp104/clpb | 1 |
186 | hvyerglycemia | 1 |
187 | hypoalaninemia | 1 |
188 | hypokalemia-hypomagnesemia-syndrome | 1 |
189 | hypomagenesemia | 1 |
190 | i-ioflupane | 1 |
191 | imipenem/cilastatine | 1 |
192 | individual-study | 1 |
193 | ingaalas | 1 |
194 | intervention/factors | 1 |
195 | lesbianism | 1 |
196 | levothroxine | 1 |
197 | lling | 1 |
198 | macrovibrations | 1 |
199 | medicinal-spiritual | 1 |
200 | metallo-enzyme | 1 |
201 | methods.there | 1 |
202 | methylpheni-date | 1 |
203 | mir-548 | 1 |
204 | mmm2 | 1 |
205 | moralize | 1 |
206 | mrgprs | 1 |
207 | nct01289743 | 1 |
208 | near-optimality | 1 |
209 | nonallergens | 1 |
210 | nonlearning | 1 |
211 | oncology-3 | 1 |
212 | one-as | 1 |
213 | orthodox-medicine | 1 |
214 | oshak16 | 1 |
215 | oxycapnography | 1 |
216 | p-0014 | 1 |
217 | perivine | 1 |
218 | pg-supplemented | 1 |
219 | phono-cardiography | 1 |
220 | photochemoprevention | 1 |
221 | pil´at | 1 |
222 | point-selecting | 1 |
223 | policy-implementation | 1 |
224 | polyurethanes.it | 1 |
225 | poor/moderate | 1 |
226 | post-bite | 1 |
227 | pre-diabetics | 1 |
228 | prostaglandin-synchronized | 1 |
229 | prunning | 1 |
230 | pyrrolidynyl | 1 |
231 | qon-v. | 1 |
232 | quinilones | 1 |
233 | raloxifine | 1 |
234 | reacclimate | 1 |
235 | recovery-ims-opa1 | 1 |
236 | research.it | 1 |
237 | rhythmopathy | 1 |
238 | rituximab-bendamustine | 1 |
239 | rostral-caudal | 1 |
240 | rostro-caudal | 1 |
241 | rs34724 | 1 |
242 | school.it | 1 |
243 | seidenf | 1 |
244 | self-enhance | 1 |
245 | ser172 | 1 |
246 | shared-decision-making | 1 |
247 | shin-ki-chon-hum | 1 |
248 | signal-2 | 1 |
249 | social-disruption | 1 |
250 | sorarú | 1 |
251 | specialties… | 1 |
252 | species-responses | 1 |
253 | spectral-efficiency | 1 |
254 | speta | 1 |
255 | sub-bloom | 1 |
256 | syn-2-clphoh | 1 |
257 | tc-3p-rgd2 | 1 |
258 | tc=1970 | 1 |
259 | timps/mmps | 1 |
260 | tissue-system | 1 |
261 | treated-hypertensive | 1 |
262 | tsn-treatment | 1 |
263 | unctional | 1 |
264 | unsupport | 1 |
265 | ureterorrenoscopy | 1 |
266 | vaccination/revaccination | 1 |
267 | walk.there | 1 |
268 | was-what | 1 |
269 | weak.there | 1 |
270 | whence | 1 |
271 | www.vioxx.com.rofecoxib | 1 |
272 | xaeds | 1 |
273 | x≈0.05 | 1 |
274 | ©2012 | 1 |
275 | α6β2β3 | 1 |
276 | β-lactones | 1 |
277 | β-sma/silica | 1 |
278 | δsuv/δgtv | 1 |
279 | √v | 1 |
280 | �absorption | 1 |
281 | �international | 1 |
282 | �³gd | 1 |
1 | ''what | 1 |
2 | 'giving | 1 |
3 | 'have | 9 |
4 | 'what | 49 |
5 | 'which | 2 |
6 | 'would | 6 |
7 | -1,4,5,6,7,8-hexahydroquinoline-3-carboxamide | 1 |
8 | -2-methylbutanoyl-l-serine | 1 |
9 | -27b | 1 |
10 | -30a-5p | 1 |
11 | -5ralpha | 1 |
12 | -avf | 1 |
13 | -coordinator | 1 |
14 | -cyclometalation | 1 |
15 | -depressants | 1 |
16 | -diffusion | 1 |
17 | -endogas | 1 |
18 | -isoamyl-3-hydroxybutanoate | 1 |
19 | -italy | 1 |
20 | -junction | 2 |
21 | -learning | 1 |
22 | -opo2o | 1 |
23 | -pacing | 1 |
24 | -tace | 1 |
25 | -β/δ | 1 |
26 | .breezhaler | 1 |
27 | .dha-p | 1 |
28 | .morphine | 1 |
29 | .selenium | 1 |
30 | .tavr | 1 |
31 | .trabectedin | 1 |
32 | //health.bsd.uchicago.edu/yji/soft.html | 1 |
33 | /c-dots | 1 |
34 | /ccn6 | 1 |
35 | /crt | 1 |
36 | /dhcr24 | 1 |
37 | /dkk-3 | 1 |
38 | /mi | 1 |
39 | /mxr/abcg2 | 1 |
40 | /tescalcin | 1 |
41 | /test | 2 |
42 | 04/30/95 | 1 |
43 | 0804 | 1 |
44 | 1,3-dihydroindol-2-ones | 1 |
45 | 1-what | 1 |
46 | 103f | 1 |
47 | 11q22-q23 | 1 |
48 | 130427a | 1 |
49 | 130k | 1 |
50 | 16_a2d | 1 |
51 | 1a1*28 | 1 |
52 | 1mg/kg/d | 1 |
53 | 2-what | 1 |
54 | 2011.results | 1 |
55 | 2014cancer | 1 |
56 | 213,543 | 1 |
57 | 23author | 1 |
58 | 25.224 | 2 |
59 | 3'-isomerization | 1 |
60 | 40-120mg/day | 1 |
61 | 45kd | 1 |
62 | 489nm | 1 |
63 | 5,353 | 1 |
64 | 580nm | 1 |
65 | 9254 | 1 |
66 | adherence/exposure | 1 |
67 | alpha-glucosaminide | 1 |
68 | antigp2b3a | 1 |
69 | anxiety.there | 1 |
70 | aot/ccot | 1 |
71 | atg14-vps30 | 2 |
72 | baishaoyao | 1 |
73 | bambusaceae | 1 |
74 | bbb-penetration | 1 |
75 | benzoyl-groups | 1 |
76 | benzoylhypacoitine | 1 |
77 | bio-membranes | 1 |
78 | biomodeling | 1 |
79 | bless | 2 |
80 | blockbusters | 1 |
81 | br38 | 5 |
82 | brd7/9 | 2 |
83 | bucast | 5 |
84 | c-trial | 1 |
85 | c.marina | 1 |
86 | c/ebp-beta | 1 |
87 | c48b6n6 | 3 |
88 | caenophanes | 3 |
89 | caldes | 1 |
90 | carbanions | 1 |
91 | carbitocin | 1 |
92 | cardiac-ct | 3 |
93 | carmel | 2 |
94 | cbm32 | 1 |
95 | cca1-e189f | 1 |
96 | cd25/cd95 | 1 |
97 | cedecea | 2 |
98 | cenes | 2 |
99 | cephaladic | 1 |
100 | chulay | 1 |
101 | clinicaltrials.govnct00162682 | 1 |
102 | clinicaltrials.govnct01202383 | 1 |
103 | cml-peptide | 2 |
104 | co-transport | 1 |
105 | cognitive-motivational | 1 |
106 | consideres | 1 |
107 | correct-the | 1 |
108 | crd42011001209 | 1 |
109 | crisis/emergent | 1 |
110 | ctip/ctbp | 1 |
111 | cullins | 1 |
112 | cyathostomins | 3 |
113 | cys289 | 1 |
114 | cytosolic-wasp | 1 |
115 | ddms | 2 |
116 | deoxyspergualin | 3 |
117 | des-venlafaxine | 1 |
118 | desmopressin.there | 1 |
119 | dihydro-1,3-benzoxazines | 1 |
120 | donna | 4 |
121 | dos3 | 4 |
122 | downfondaparinux | 1 |
123 | drug.there | 1 |
124 | dynquest | 2 |
125 | efavirens | 1 |
126 | epithelia/endothelia | 1 |
127 | epy | 1 |
128 | eradicate.this | 1 |
129 | etconhc6h5 | 1 |
130 | euforbiaceae | 1 |
131 | exchange-relevant | 1 |
132 | experimental-treatment | 1 |
133 | f420h2 | 1 |
134 | fe-f6 | 1 |
135 | few-layered | 1 |
136 | food-reward | 1 |
137 | frenzel | 1 |
138 | frhb | 1 |
139 | giig | 3 |
140 | glyco-proteomics | 1 |
141 | hausera | 1 |
142 | havcr1/kim-1 | 1 |
143 | hbot.there | 1 |
144 | high-fat/lower | 1 |
145 | his359 | 1 |
146 | hla-drβ1*04:02 | 1 |
147 | homoproline | 1 |
148 | hospital.this | 1 |
149 | hsp104/clpb | 1 |
150 | htlvs | 2 |
151 | hvyerglycemia | 1 |
152 | hypoalaninemia | 1 |
153 | hypochromy | 3 |
154 | hypokalemia-hypomagnesemia-syndrome | 1 |
155 | hypomagenesemia | 1 |
156 | i-ioflupane | 1 |
157 | illness-spectrum | 2 |
158 | imipenem/cilastatine | 1 |
159 | immunodrugs | 2 |
160 | individual-study | 1 |
161 | ingaalas | 1 |
162 | ingn-225 | 5 |
163 | intervention/factors | 1 |
164 | kristin | 2 |
165 | kushta | 2 |
166 | leisure-related | 3 |
167 | lesbianism | 1 |
168 | levothroxine | 1 |
169 | liliopsida | 3 |
170 | lling | 1 |
171 | macrovibrations | 1 |
172 | man7glcnac2 | 2 |
173 | medicinal-spiritual | 1 |
174 | metallo-enzyme | 1 |
175 | methods.there | 1 |
176 | methylpheni-date | 1 |
177 | mir-548 | 1 |
178 | mk-0888 | 5 |
179 | mmm2 | 1 |
180 | moralize | 1 |
181 | mrgprs | 1 |
182 | namisol | 2 |
183 | nct01289743 | 1 |
184 | near-optimality | 1 |
185 | neville | 3 |
186 | nonallergens | 1 |
187 | nonlearning | 1 |
188 | nowhere | 15 |
189 | octrestatin | 2 |
190 | oncology-3 | 1 |
191 | one-as | 1 |
192 | orthodox-medicine | 1 |
193 | oshak16 | 1 |
194 | oxycapnography | 1 |
195 | p-0014 | 1 |
196 | p50/rela | 2 |
197 | pde1c | 6 |
198 | peniscopy | 2 |
199 | perivine | 1 |
200 | pg-supplemented | 1 |
201 | phono-cardiography | 1 |
202 | photochemoprevention | 1 |
203 | pil´at | 1 |
204 | point-selecting | 1 |
205 | policy-implementation | 1 |
206 | polyurethanes.it | 1 |
207 | poor/moderate | 1 |
208 | post-bite | 1 |
209 | pre-diabetics | 1 |
210 | progesteron | 2 |
211 | prostaglandin-synchronized | 1 |
212 | protocol-related | 3 |
213 | prunning | 1 |
214 | pyrrolidynyl | 1 |
215 | qon-v. | 1 |
216 | quinilones | 1 |
217 | raloxifine | 1 |
218 | re-start | 3 |
219 | reacclimate | 1 |
220 | recovery-ims-opa1 | 1 |
221 | research.it | 1 |
222 | retro-cuing | 3 |
223 | rewording | 2 |
224 | rhaiii | 3 |
225 | rhythmopathy | 1 |
226 | rituximab-bendamustine | 1 |
227 | rochon | 2 |
228 | rostral-caudal | 1 |
229 | rostro-caudal | 1 |
230 | rs/ef | 2 |
231 | rs34724 | 1 |
232 | s1333 | 4 |
233 | school.it | 1 |
234 | seidenf | 1 |
235 | self-enhance | 1 |
236 | ser172 | 1 |
237 | shared-decision-making | 1 |
238 | shin-ki-chon-hum | 1 |
239 | signal-2 | 1 |
240 | social-disruption | 1 |
241 | sorarú | 1 |
242 | specialties… | 1 |
243 | species-responses | 1 |
244 | spectral-efficiency | 1 |
245 | speta | 1 |
246 | sub-bloom | 1 |
247 | sulfamides | 2 |
248 | svm-ref | 2 |
249 | swach | 8 |
250 | syn-2-clphoh | 1 |
251 | syngnathids | 2 |
252 | tc-3p-rgd2 | 1 |
253 | tc=1970 | 1 |
254 | timps/mmps | 1 |
255 | tissue-system | 1 |
256 | treated-hypertensive | 1 |
257 | tsn-treatment | 1 |
258 | unctional | 1 |
259 | unsupport | 1 |
260 | ureterorrenoscopy | 1 |
261 | vaccination/revaccination | 1 |
262 | walk.there | 1 |
263 | was-what | 1 |
264 | weak.there | 1 |
265 | what | 6,740 |
266 | whence | 1 |
267 | whoever | 3 |
268 | www.vioxx.com.rofecoxib | 1 |
269 | xaeds | 1 |
270 | x≈0.05 | 1 |
271 | zmhsp17.8-cii | 4 |
272 | ©2012 | 1 |
273 | α-li3bn2 | 3 |
274 | α6β2β3 | 1 |
275 | β-lactones | 1 |
276 | β-sma/silica | 1 |
277 | δsuv/δgtv | 1 |
278 | “what | 2 |
279 | √v | 1 |
280 | �absorption | 1 |
281 | �international | 1 |
282 | �³gd | 1 |
1 | qon-v. | 1 |
2 | atg14-vps30 | 2 |
3 | tc=1970 | 1 |
4 | havcr1/kim-1 | 1 |
5 | recovery-ims-opa1 | 1 |
6 | signal-2 | 1 |
7 | hla-drβ1*04:02 | 1 |
8 | ©2012 | 1 |
9 | cbm32 | 1 |
10 | ser172 | 1 |
11 | clinicaltrials.govnct00162682 | 1 |
12 | man7glcnac2 | 2 |
13 | tc-3p-rgd2 | 1 |
14 | /mxr/abcg2 | 1 |
15 | f420h2 | 1 |
16 | mmm2 | 1 |
17 | α-li3bn2 | 3 |
18 | /dkk-3 | 1 |
19 | oncology-3 | 1 |
20 | 11q22-q23 | 1 |
21 | s1333 | 4 |
22 | 213,543 | 1 |
23 | nct01289743 | 1 |
24 | 5,353 | 1 |
25 | clinicaltrials.govnct01202383 | 1 |
26 | dos3 | 4 |
27 | α6β2β3 | 1 |
28 | 0804 | 1 |
29 | p-0014 | 1 |
30 | 25.224 | 2 |
31 | rs34724 | 1 |
32 | /dhcr24 | 1 |
33 | 9254 | 1 |
34 | x≈0.05 | 1 |
35 | ingn-225 | 5 |
36 | 04/30/95 | 1 |
37 | cd25/cd95 | 1 |
38 | etconhc6h5 | 1 |
39 | oshak16 | 1 |
40 | fe-f6 | 1 |
41 | c48b6n6 | 3 |
42 | /ccn6 | 1 |
43 | 1a1*28 | 1 |
44 | br38 | 5 |
45 | mir-548 | 1 |
46 | mk-0888 | 5 |
47 | brd7/9 | 2 |
48 | crd42011001209 | 1 |
49 | his359 | 1 |
50 | cys289 | 1 |
51 | antigp2b3a | 1 |
52 | 130427a | 1 |
53 | β-sma/silica | 1 |
54 | liliopsida | 3 |
55 | cedecea | 2 |
56 | -5ralpha | 1 |
57 | epithelia/endothelia | 1 |
58 | hvyerglycemia | 1 |
59 | hypoalaninemia | 1 |
60 | hypomagenesemia | 1 |
61 | p50/rela | 2 |
62 | c.marina | 1 |
63 | donna | 4 |
64 | hausera | 1 |
65 | c/ebp-beta | 1 |
66 | speta | 1 |
67 | kushta | 2 |
68 | -27b | 1 |
69 | frhb | 1 |
70 | www.vioxx.com.rofecoxib | 1 |
71 | hsp104/clpb | 1 |
72 | pde1c | 6 |
73 | cephaladic | 1 |
74 | 1mg/kg/d | 1 |
75 | 16_a2d | 1 |
76 | few-layered | 1 |
77 | leisure-related | 3 |
78 | protocol-related | 3 |
79 | pg-supplemented | 1 |
80 | prostaglandin-synchronized | 1 |
81 | �³gd | 1 |
82 | 45kd | 1 |
83 | 'would | 6 |
84 | food-reward | 1 |
85 | euforbiaceae | 1 |
86 | bambusaceae | 1 |
87 | -tace | 1 |
88 | self-enhance | 1 |
89 | whence | 1 |
90 | -1,4,5,6,7,8-hexahydroquinoline-3-carboxamide | 1 |
91 | alpha-glucosaminide | 1 |
92 | cml-peptide | 2 |
93 | correct-the | 1 |
94 | neville | 3 |
95 | hypokalemia-hypomagnesemia-syndrome | 1 |
96 | metallo-enzyme | 1 |
97 | i-ioflupane | 1 |
98 | orthodox-medicine | 1 |
99 | raloxifine | 1 |
100 | .morphine | 1 |
101 | homoproline | 1 |
102 | -2-methylbutanoyl-l-serine | 1 |
103 | imipenem/cilastatine | 1 |
104 | benzoylhypacoitine | 1 |
105 | rituximab-bendamustine | 1 |
106 | perivine | 1 |
107 | des-venlafaxine | 1 |
108 | levothroxine | 1 |
109 | drug.there | 1 |
110 | weak.there | 1 |
111 | walk.there | 1 |
112 | desmopressin.there | 1 |
113 | methods.there | 1 |
114 | hbot.there | 1 |
115 | anxiety.there | 1 |
116 | nowhere | 15 |
117 | adherence/exposure | 1 |
118 | methylpheni-date | 1 |
119 | reacclimate | 1 |
120 | -isoamyl-3-hydroxybutanoate | 1 |
121 | poor/moderate | 1 |
122 | post-bite | 1 |
123 | 'have | 9 |
124 | treated-hypertensive | 1 |
125 | moralize | 1 |
126 | 103f | 1 |
127 | cca1-e189f | 1 |
128 | rs/ef | 2 |
129 | svm-ref | 2 |
130 | seidenf | 1 |
131 | -avf | 1 |
132 | giig | 3 |
133 | -pacing | 1 |
134 | rewording | 2 |
135 | shared-decision-making | 1 |
136 | biomodeling | 1 |
137 | lling | 1 |
138 | prunning | 1 |
139 | -learning | 1 |
140 | nonlearning | 1 |
141 | point-selecting | 1 |
142 | retro-cuing | 3 |
143 | 'giving | 1 |
144 | swach | 8 |
145 | 'which | 2 |
146 | syn-2-clphoh | 1 |
147 | zmhsp17.8-cii | 4 |
148 | rhaiii | 3 |
149 | /mi | 1 |
150 | 130k | 1 |
151 | rostral-caudal | 1 |
152 | rostro-caudal | 1 |
153 | c-trial | 1 |
154 | �international | 1 |
155 | cognitive-motivational | 1 |
156 | unctional | 1 |
157 | medicinal-spiritual | 1 |
158 | carmel | 2 |
159 | frenzel | 1 |
160 | //health.bsd.uchicago.edu/yji/soft.html | 1 |
161 | namisol | 2 |
162 | pyrrolidynyl | 1 |
163 | tissue-system | 1 |
164 | 580nm | 1 |
165 | 489nm | 1 |
166 | sub-bloom | 1 |
167 | lesbianism | 1 |
168 | shin-ki-chon-hum | 1 |
169 | .selenium | 1 |
170 | illness-spectrum | 2 |
171 | /tescalcin | 1 |
172 | carbitocin | 1 |
173 | .trabectedin | 1 |
174 | deoxyspergualin | 3 |
175 | octrestatin | 2 |
176 | kristin | 2 |
177 | rochon | 2 |
178 | -diffusion | 1 |
179 | -cyclometalation | 1 |
180 | vaccination/revaccination | 1 |
181 | bbb-penetration | 1 |
182 | policy-implementation | 1 |
183 | 3'-isomerization | 1 |
184 | -junction | 2 |
185 | photochemoprevention | 1 |
186 | �absorption | 1 |
187 | social-disruption | 1 |
188 | progesteron | 2 |
189 | -opo2o | 1 |
190 | baishaoyao | 1 |
191 | .dha-p | 1 |
192 | -30a-5p | 1 |
193 | ctip/ctbp | 1 |
194 | cytosolic-wasp | 1 |
195 | 2014cancer | 1 |
196 | .breezhaler | 1 |
197 | whoever | 3 |
198 | high-fat/lower | 1 |
199 | 23author | 1 |
200 | -coordinator | 1 |
201 | .tavr | 1 |
202 | one-as | 1 |
203 | -endogas | 1 |
204 | ingaalas | 1 |
205 | glyco-proteomics | 1 |
206 | pre-diabetics | 1 |
207 | xaeds | 1 |
208 | syngnathids | 2 |
209 | sulfamides | 2 |
210 | caldes | 1 |
211 | caenophanes | 3 |
212 | bio-membranes | 1 |
213 | cenes | 2 |
214 | dihydro-1,3-benzoxazines | 1 |
215 | 1,3-dihydroindol-2-ones | 1 |
216 | quinilones | 1 |
217 | β-lactones | 1 |
218 | consideres | 1 |
219 | species-responses | 1 |
220 | immunodrugs | 2 |
221 | eradicate.this | 1 |
222 | hospital.this | 1 |
223 | ddms | 2 |
224 | nonallergens | 1 |
225 | efavirens | 1 |
226 | cullins | 1 |
227 | cyathostomins | 3 |
228 | carbanions | 1 |
229 | macrovibrations | 1 |
230 | timps/mmps | 1 |
231 | benzoyl-groups | 1 |
232 | blockbusters | 1 |
233 | intervention/factors | 1 |
234 | mrgprs | 1 |
235 | bless | 2 |
236 | 2011.results | 1 |
237 | -depressants | 1 |
238 | /c-dots | 1 |
239 | htlvs | 2 |
240 | what | 6,740 |
241 | 'what | 49 |
242 | ''what | 1 |
243 | 1-what | 1 |
244 | 2-what | 1 |
245 | was-what | 1 |
246 | “what | 2 |
247 | pil´at | 1 |
248 | cardiac-ct | 3 |
249 | research.it | 1 |
250 | school.it | 1 |
251 | polyurethanes.it | 1 |
252 | exchange-relevant | 1 |
253 | crisis/emergent | 1 |
254 | experimental-treatment | 1 |
255 | tsn-treatment | 1 |
256 | aot/ccot | 1 |
257 | re-start | 3 |
258 | /crt | 1 |
259 | unsupport | 1 |
260 | co-transport | 1 |
261 | bucast | 5 |
262 | /test | 2 |
263 | dynquest | 2 |
264 | δsuv/δgtv | 1 |
265 | √v | 1 |
266 | downfondaparinux | 1 |
267 | 40-120mg/day | 1 |
268 | chulay | 1 |
269 | spectral-efficiency | 1 |
270 | individual-study | 1 |
271 | phono-cardiography | 1 |
272 | oxycapnography | 1 |
273 | rhythmopathy | 1 |
274 | -italy | 1 |
275 | hypochromy | 3 |
276 | epy | 1 |
277 | peniscopy | 2 |
278 | ureterorrenoscopy | 1 |
279 | near-optimality | 1 |
280 | specialties… | 1 |
281 | -β/δ | 1 |
282 | sorarú | 1 |